MACROPHAGE-CENTRIC PROGNOSTIC BIOMARKERS FOR CHECKPOINT BLOCKADE IMMUNOTHERAPY IN MELANOMA

$1,317,584FY2025Defense Health AgencyDOD

University Of Alabama At Birmingham, Birmingham AL

Investigators